Agios Pharms Inc Company Profile
✉ Email this page to a colleague
What is the competitive landscape for AGIOS PHARMS INC
AGIOS PHARMS INC has one approved drug.
There are nine US patents protecting AGIOS PHARMS INC drugs.
Summary for Agios Pharms Inc
| US Patents: | 9 |
| Tradenames: | 2 |
| Ingredients: | 1 |
| NDAs: | 1 |
Drugs and US Patents for Agios Pharms Inc
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Agios Pharms Inc | AQVESME | mitapivat sulfate | TABLET;ORAL | 216196-004 | Dec 23, 2025 | RX | Yes | Yes | 10,632,114 | ⤷ Start Trial | ⤷ Start Trial | ||||
| Agios Pharms Inc | PYRUKYND | mitapivat sulfate | TABLET;ORAL | 216196-003 | Feb 17, 2022 | RX | Yes | Yes | 11,793,806 | ⤷ Start Trial | ⤷ Start Trial | ||||
| Agios Pharms Inc | AQVESME | mitapivat sulfate | TABLET;ORAL | 216196-004 | Dec 23, 2025 | RX | Yes | Yes | ⤷ Start Trial | ⤷ Start Trial | |||||
| Agios Pharms Inc | PYRUKYND | mitapivat sulfate | TABLET;ORAL | 216196-001 | Feb 17, 2022 | RX | Yes | No | 11,793,806 | ⤷ Start Trial | ⤷ Start Trial | ||||
| Agios Pharms Inc | PYRUKYND | mitapivat sulfate | TABLET;ORAL | 216196-001 | Feb 17, 2022 | RX | Yes | No | 9,193,701 | ⤷ Start Trial | ⤷ Start Trial | ||||
| Agios Pharms Inc | PYRUKYND | mitapivat sulfate | TABLET;ORAL | 216196-002 | Feb 17, 2022 | RX | Yes | No | 11,254,652 | ⤷ Start Trial | Y | Y | ⤷ Start Trial | ||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for Agios Pharms Inc Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| China | 102481300 | ⤷ Start Trial |
| Costa Rica | 20170071 | ⤷ Start Trial |
| Spain | 2959690 | ⤷ Start Trial |
| Morocco | 44392 | ⤷ Start Trial |
| South Korea | 20180079451 | ⤷ Start Trial |
| South Korea | 101712035 | ⤷ Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Agios Pharms Inc Drugs
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 2448582 | CA 2023 00014 | Denmark | ⤷ Start Trial | PRODUCT NAME: MITAPIVAT ELLER ET FARMACEUTISK ACCEPTABELT SALT DERAF, ISAER MITAPIVATSULFAT; REG. NO/DATE: EU/1/22/1662 20221110 |
| 2448582 | 19/2023 | Austria | ⤷ Start Trial | PRODUCT NAME: MITAPIVAT ODER EIN PHARMAZEUTISCH ANNEHMBARES SALZ DAVON, INSBESONDERE MITAPIVAT-SULFAT; REGISTRATION NO/DATE: EU/1/22/1662 (MITTEILUNG) 20221110 |
| 2448582 | C202330019 | Spain | ⤷ Start Trial | PRODUCT NAME: MITAPIVAT O UNA SAL FARMACEUTICAMENTE ACEPTABLE DEL MISMO, EN PARTICULAR SULFATO DE MITAPIVAT; NATIONAL AUTHORISATION NUMBER: EU/1/22/1662; DATE OF AUTHORISATION: 20221109; NUMBER OF FIRST AUTHORISATION IN EUROPEAN ECONOMIC AREA (EEA): EU/1/22/1662; DATE OF FIRST AUTHORISATION IN EEA: 20221109 |
| 2448582 | PA2023513,C2448582 | Lithuania | ⤷ Start Trial | PRODUCT NAME: MITAPIVATAS ARBA JO FARMACINIU POZIURIU PRIIMTINA DRUSKA, YPAC MITAPIVATO SULFATAS; REGISTRATION NO/DATE: EU/1/22/1662 20221109 |
| 2448582 | CR 2023 00014 | Denmark | ⤷ Start Trial | PRODUCT NAME: MITAPIVAT ELLER ET FARMACEUTISK ACCEPTABELT SALT DERAF, ISAER MITAPIVATSULFAT; REG. NO/DATE: EU/1/22/1662 20221110 |
| 2448582 | 2390014-5 | Sweden | ⤷ Start Trial | PRODUCT NAME: MITAPIVAT OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, IN PARTICULAR MITAPIVAT SULFATE; REG. NO/DATE: EU/1/22/1662 20221110 |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
